Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ketamine for Acute Pain After Amputation
NCT02341963Phase 1Terminated
- Sponsor
- Rush University Medical Center
- Start
- Jan 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in acute pain, phantom limb pain (PLP) and Residual limb pain (RLP), sponsored by Rush University Medical Center. Primary endpoint: Incidence of Adverse Events. Started Jan 2015; status: terminated.
02
Drugs
ketamine
03
Conditions
acute painphantom limb pain (PLP)Residual limb pain (RLP)
Beyond the preview
Go deeper on NCT02341963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02341963.